Telithromycin: an oral ketolide for respiratory infections. - Wikidata - awgldk - TriplyDB

Telithromycin: an oral ketolide for respiratory infections.

Telithromycin: an oral ketolide for respiratory infections.

http://www.wikidata.org/entity/Q34401542

about

Telithromycin: a novel agent for the treatment of community-acquired upper respiratory infections Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport Novel antibacterial agents for the treatment of serious Gram-positive infections.Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 2: human trials.Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.Alterations in regulatory regions of erm(B) genes from clinical isolates of enterococci resistant to telithromycin

P2860

Q33945038-DA93B597-2151-4C14-99D7-9BD6C130FED6 Q34281970-A85DD3F5-994E-4280-B288-A752E5EBF191 Q34301527-73085E0B-AAEA-4631-96AF-7803C2F90F7D Q35073345-ECA52CC6-09E9-49A1-8AA9-30D0B2A506BD Q35547236-3E3ED5EA-1C80-4AD9-8795-CB975F25D3FD Q45057564-A9338608-C36C-4C8D-9CD9-889BE86D8F17 Q57226019-7E5D8234-8E63-44A9-8D56-D73C4DDA35CD

P2860

Telithromycin: an oral ketolide for respiratory infections.

http://www.wikidata.org/entity/Q34401542

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Telithromycin: an oral ketolide for respiratory infections.

@ast

Telithromycin: an oral ketolide for respiratory infections.

@en

Telithromycin: an oral ketolide for respiratory infections.

@nl

type

label

Telithromycin: an oral ketolide for respiratory infections.

@ast

Telithromycin: an oral ketolide for respiratory infections.

@en

Telithromycin: an oral ketolide for respiratory infections.

@nl

prefLabel

Telithromycin: an oral ketolide for respiratory infections.

@ast

Telithromycin: an oral ketolide for respiratory infections.

@en

Telithromycin: an oral ketolide for respiratory infections.

@nl

P1433

Q34401542-0D0C4568-935D-4222-9BAF-75334E99FC7A

P1476

Q34401542-74212C06-058A-43A6-BB3B-36E2BBC8FB31

P2093

Q34401542-0753A1F1-4023-4DCF-9D00-2A01A3CAD9DD

Q34401542-3C274984-0DA3-4C82-BCB0-7121B329506C

Q34401542-AB1307EE-F94B-4966-8AD0-230C82706646

P2860

Q34401542-07770744-37C7-4F7E-A0AC-28C0750A3A2C

Q34401542-09861BF4-BEE7-4E21-8AD6-08479D45FD16

Q34401542-12947437-9C21-4CCA-B4F0-296A311C768B

Q34401542-144367BB-51DF-4E20-943A-36F1D8F7EDE4

Q34401542-1595178F-6788-42C5-B890-427934276CAB

Q34401542-17E43A3A-8568-49DF-9EA4-2B5EEBC27881

Q34401542-23613FAB-CA77-4CE8-AC4F-7DC8E12B9A56

Q34401542-2E3BC95C-3901-4FA2-9B57-5913BB1F1E63

Q34401542-2F32AD02-A75E-4063-8AC3-64C520EA25FB

Q34401542-36507EB9-6FAC-40A8-818D-DC6E503804A3

P304

Q34401542-3914232E-2E7C-494F-A25C-721323D100A2

P31

Q34401542-2B501043-C070-419F-BA04-97D526DF6F96

P356

Q34401542-9C9F8A7D-EF8F-4A5E-9D7D-200BC1FFD4ED

P407

Q34401542-B3B22C32-9200-4C30-93DA-11D038C44B9E

P433

Q34401542-51932C5B-6B3C-47E3-83E4-D91DD8176F64

P478

Q34401542-1DEE1E1E-D1CE-4139-89A0-F1AA01B9A589

P577

Q34401542-930A8168-BF9A-4449-AF5B-7C9CB4CF2BF5

P698

Q34401542-D29CC83B-93FF-4BBB-A9C3-7A2AAD6D9EFC

P356

PHCO.21.15.1204.33902

P1433

Pharmacotherapy

P1476

Telithromycin: an oral ketolide for respiratory infections.

@en

P2093

D T Bearden

http://www.w3.org/2001/XMLSchema#string

K W Garey

http://www.w3.org/2001/XMLSchema#string

M M Neuhauser

http://www.w3.org/2001/XMLSchema#string

P2860

A prediction rule to identify low-risk patients with community-acquired pneumonia

In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials

In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4

Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre.

Streptococcus pneumoniae: new tools for an old pathogen.

Pharmacokinetics of the new ketolide telithromycin (HMR 3647) administered in ascending single and multiple doses.

Pneumococcal macrolide resistance--myth or reality?

Recent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance.

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

P304

1204-1222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.21.15.1204.33902

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11601667

http://www.w3.org/2001/XMLSchema#string